Stryker (SYK) Long-Term Investments (2009 - 2010)
Stryker (SYK) reported Long-Term Investments of -$110.0 million for Q4 2010, down 170.06% year-over-year from $157.0 million in Q4 2009, and down 170.06% on a QoQ basis from $157.0 million in Q4 2009.
Stryker (SYK) has 2 years of Long-Term Investments data on file, last reported at -$110.0 million in Q4 2010.
- Quarterly Long-Term Investments fell 170.06% year-over-year to -$110.0 million in Q4 2010, while the trailing twelve-month figure through Dec 2010 was -$110.0 million (down 170.06% YoY) and the FY2010 annual result came in at -$110.0 million, down 170.06% from the prior year.
- Long-Term Investments slipped to -$110.0 million in Q4 2010 per SYK's latest filing, from $157.0 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $157.0 million in Q4 2009 and bottomed at -$110.0 million in Q4 2010.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 166.25 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | -110.00 Mn |
| Dec 31, 2009 | 157.00 Mn |